Combination Therapy with Dapagliflozin and Saxagliptin prevents diabetes-induced inflammation and organ injury by targeting the Nirp3/ASC inflammasome

  • Ye, Yumei (PI)

Project: Other project

Project Details

StatusFinished
Effective start/end date12/17/15 → 6/30/18